vimarsana.com

Latest Breaking News On - Alex pastuszak - Page 1 : vimarsana.com

Meet the husband who had a vasectomy to avoid pregnancy following wife's miscarriages

When a couple tried to conceive three times, but it all ended in miscarriage, the husband decided to get a vasectomy to avoid any future pregnancies. They are now preparing to adopt their first child.

Alex-pastuszak
University-of-utah
National-library-of-medicine
National-library
Fertility

AS LIFE EXPECTANCY FOR MEN IN THE UNITED STATES DECLINES, PRIORITIZING HEALTH IS ESSENTIAL

/PRNewswire/ BACKGROUND: Life expectancy for men in the United States continues to decline, recently hitting levels not seen in nearly two decades.1 A.

New-york
United-states
California
San-francisco
American
Salvatorej-giorgianni
Alexanderw-pastuszak
Alex-pastuszak
Salvatore-giorgianni
Heather-zoumas-lubeski
University-of-california
Mental-health

Brooks: By spit or by swab, testing is powerful pandemic weapon

Rates of Erythrocytosis in Trans Males Consistent with Cis Males

Rates of Erythrocytosis in Trans Males Consistent with Cis Males New research found that the greatest increases in hematocrit occurred during the first year of treatment but levels continue to increase over time until around the 20 year mark With Milou Madsen MD and Alex Pastuszak MD In the decade between 2001 and 2011, the number of prescriptions for testosterone for men over 40 tripled. It quadrupled for those 18-45. These sharp increases in men starting hormone therapy after reporting symptoms of hypogonadism has led some to speculate on the side effects of testosterone therapy, including erythrocytosis. This increase in the red blood cell population can result in symptoms that can be health or life-threatening, including obstructive sleep apnea, kidney stones, stroke, deep vein thrombosis or heart attack.

Netherlands
Amsterdam
Noord-holland
Milou-cecilia-madsenm
University-of-amsterdam-medical-center
University-of-utah
With-milou-madsen
Alex-pastuszak
Large-cohort
Trans-men-using-testosterone
Long-term-follow
Milous-madsen

UConn-Developed Diagnostic Test for Infectious Diseases Reaches Licensing Deal

UConn-Developed Diagnostic Test for Infectious Diseases Reaches Licensing Deal The method enables simple, rapid detection of SARS-CoV-2 and other diseases. (Getty Images) Copy Link A simple, low-cost method of detecting infectious diseases developed by researchers at UConn has reached a licensing deal with Vault Medical Services. In March 2020, researchers in the Department of Biomedical Engineering a shared department in the schools of Dental Medicine, Medicine, and Engineering began to develop a new, low-cost, CRISPR-based diagnostic platform to detect infectious diseases, including HIV and the novel coronavirus (SARS-CoV-2). Led by associate professor Changchun Liu, the “All-In-One-Dual CRISPR-Cas12a” (AIOD-CRISPR) method enables simple, rapid, ultrasensitive, visual detection of SARS-CoV-2, intended for use at home or in small clinics.

New-york
United-states
Connecticut
Alex-pastuszak
Amit-kumar
Department-of-biomedical-engineering
Uconn-technology-commercialization-services
Uconn-research-technology-commercialization-services
Vault-medical
Biomedical-engineering
Dental-medicine
Changchun-liu

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.